Among the 106 identified target genes, some have been previously implicated in hematopoietic malignancies, such as EBF1, MYB, and ETS1, while others, including DCTD, have not been previously linked to BCP-ALL. Here, DCTD is linked to acute lymphoblastic leukemia.